stoxline Quote Chart Rank Option Currency Glossary
  
Inari Medical, Inc. (NARI)
79.97  0 (0%)    02-18 16:00
Open: 79.96
High: 79.97
Volume: 2,356,692
  
Pre. Close: 79.97
Low: 79.96
Market Cap: 4,683(M)
Technical analysis
2025-03-21 4:46:01 PM
Short term     
Mid term     
Targets 6-month :  93.4 1-year :  109.09
Resists First :  79.97 Second :  93.4
Pivot price 79.83
Supports First :  79.54 Second :  79.29
MAs MA(5) :  79.94 MA(20) :  79.78
MA(100) :  58.25 MA(250) :  51.08
MACD MACD :  2.5 Signal :  3.3
%K %D K(14,3) :  96.8 D(3) :  95
RSI RSI(14): 79.6
52-week High :  79.97 Low :  36.72
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ NARI ] has closed below upper band by 19.4%. Bollinger Bands are 96.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 80.09 - 80.49 80.49 - 80.82
Low: 79.02 - 79.45 79.45 - 79.81
Close: 79.34 - 80.01 80.01 - 80.57
Company Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Headline News

Wed, 19 Feb 2025
Stryker's Strategic Move: How Inari's Blood Clot Solutions Transform Its Market Position - Stock Titan

Wed, 19 Feb 2025
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment - GlobeNewswire

Fri, 17 Jan 2025
Stryker Launches $80 Per Share Cash Tender Offer for Inari Medical Acquisition - Stock Titan

Fri, 17 Jan 2025
Here’s Why Inari Medical, Inc. (NARI) Is Skyrocketing - Yahoo Finance

Tue, 07 Jan 2025
Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock? - Yahoo Finance

Tue, 07 Jan 2025
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B - Investopedia

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 59 (M)
Shares Float 53 (M)
Held by Insiders 9 (%)
Held by Institutions 95.5 (%)
Shares Short 2,480 (K)
Shares Short P.Month 3,840 (K)
Stock Financials
EPS -1.36
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.44
Profit Margin -13.7 %
Operating Margin -4.4 %
Return on Assets (ttm) -3.3 %
Return on Equity (ttm) -17.8 %
Qtrly Rev. Growth 21.3 %
Gross Profit (p.s.) 8.51
Sales Per Share 9.81
EBITDA (p.s.) -0.45
Qtrly Earnings Growth 0 %
Operating Cash Flow 14 (M)
Levered Free Cash Flow 87 (M)
Stock Valuations
PE Ratio -59.24
PEG Ratio 0
Price to Book value 10.74
Price to Sales 8.15
Price to Cash Flow 330.25
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android